Free Trial
NASDAQ:PDEX

Pro-Dex Q2 2025 Earnings Report

Pro-Dex logo
$46.19 -1.08 (-2.28%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$46.10 -0.09 (-0.19%)
As of 07/18/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pro-Dex EPS Results

Actual EPS
$0.61
Consensus EPS
$0.38
Beat/Miss
Beat by +$0.23
One Year Ago EPS
N/A

Pro-Dex Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pro-Dex Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, January 30, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Pro-Dex's Q4 2025 earnings is scheduled for Thursday, September 4, 2025, with a conference call scheduled on Thursday, August 28, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Pro-Dex Earnings Headlines

Pro-Dex, Inc. (PDEX) - Yahoo Finance
America’s new national emergency…
Porter Stansberry says we’re not in a normal market cycle — we’re in a government-triggered economic reordering unlike anything since WWII. Trillions are already being mobilized. In this urgent broadcast, Porter and Jeff Brown reveal the single force driving it all… and name the two stocks most likely to benefit.
See More Pro-Dex Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pro-Dex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pro-Dex and other key companies, straight to your email.

About Pro-Dex

Pro-Dex (NASDAQ:PDEX) (NASDAQ: PDEX) is a precision manufacturing company specializing in the design and production of components and instruments for the medical, dental and life sciences industries. The company’s product portfolio encompasses a wide range of precision-machined parts, automated torque devices, endoscopic instruments, biopsy needles, trocars, and custom cable assemblies. Pro-Dex serves original equipment manufacturers and distributors, providing both standalone products and integrated subassemblies to support complex medical and dental procedures.

Founded in 1982, Pro-Dex has built a reputation for engineering expertise and quality control, holding certifications such as ISO 13485 for medical device production. Headquartered in California, the company operates multiple manufacturing facilities across the United States, with sales and distribution networks extending into Europe and Asia. Over its history, Pro-Dex has invested in state-of-the-art CNC machining centers, cleanroom assembly lines and automated inspection equipment to ensure precision, consistency and regulatory compliance.

Pro-Dex’s business model is organized into two key segments: MedTech and Dental. The MedTech segment focuses on critical surgical and diagnostic instruments, including custom torque wrenches, endoscopic tools, and minimally invasive surgical devices. The Dental segment produces high-tolerance components and consumables for restorative and orthodontic applications, ranging from implant abutments to orthodontic wire assemblies. Both segments benefit from the company’s vertically integrated manufacturing capabilities and its proprietary quality management systems.

Governance and leadership at Pro-Dex are guided by a seasoned management team with extensive experience in precision manufacturing and medical device development. The executive group is supported by a board of directors that emphasizes operational excellence, continuous improvement and compliance with global regulatory standards. Through strategic investments in technology and capacity expansion, Pro-Dex is positioned to meet growing demand for advanced medical and dental solutions worldwide.

View Pro-Dex Profile

More Earnings Resources from MarketBeat